Case report: The case of T-cell acute lymphoblastic leukemia treated with chemotherapy followed by anti-CD7 CAR-T cells using retroviral vector
CD7-targeted chimeric antigen receptor-T (CAR-T) cell therapy has shown great promise in the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL). In this study, we reported a case of a 34-year-old male patient with T-ALL who finally developed multi-line drug resistance and r...
Saved in:
Main Authors: | Huanhuan Zhou, Wenxiang Zhu, Qihong Ma, Ning Liu, Mengdi Jin, Yaru Feng, Lijun Zhao, Rui Sun, Rongyou Li, Huaxiu Li, Yuanyuan Shi, Jianxun Wang, Liqiong Liu, Zhi Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1519055/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS
by: Ugo Testa, et al.
Published: (2024-01-01) -
CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity
by: Yaojie Kong, et al.
Published: (2025-01-01) -
Pseudoprogression in CAR-T cell therapy for solid tumor: Case report
by: Xuan Zhao, et al.
Published: (2025-01-01) -
DETERMINATION OF THE QUALITY INDEX OF CARS
by: Oleksiy BAZHINOV, et al.
Published: (2023-03-01) -
CAR-T Therapy Beyond B-Cell Hematological Malignancies
by: Martina Canichella, et al.
Published: (2025-01-01)